Philips (PHG) announced it has entered into an agreement to acquire SpectraWAVE. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide solutions for the treatment of patients with coronary artery disease. SpectraWAVE, based in Bedford, Massachusetts, was founded in 2017 and currently employs more than 70 people. Financial terms of the agreement were not disclosed.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Hold Rating for Koninklijke Philips N.V. Amid Sector Challenges and Company-Specific Uncertainties
- Philips price target raised to EUR 19.60 from EUR 18.30 at JPMorgan
- Philips reaffirms timing of 2026 outlook
- Philips expands commercial availability of LumiGuide 3D Device Guidance
- Philips unveils BlueSeal Horizon, a new 3.0T MRI platform